Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

538 Press Releases
DateTitleCompany
22 Mar 11 Merck and sanofi-aventis to Maintain Separate Businesses in Animal Health Merck and sanofi-aventis,
Published by
Business Wire
15 Mar 11 Merck to Present at Barclays Capital 2011 Global Healthcare Conference Merck,
Published by
Business Wire
07 Mar 11 Merck Announces New Data Analyses for VICTRELIS™ (Boceprevir) will be Presented at The International Liver CongressTM / 2011 EASL Annual Meeting Merck & Co. Inc.,
Published by
Business Wire
07 Mar 11 Merck to Present at Cowen and Company's 31st Annual Health Care Conference Merck,
Published by
Business Wire
02 Mar 11 Merck’s ISENTRESS® (raltegravir) Demonstrated Durable Reductions in HIV-1 Viral Load and Sustained Tolerability At Three Years of Treatment in Previously Untreated Adult Patients Infected with HIV-1 Merck & Co. Inc.,
Published by
Business Wire
01 Mar 11 Merck to Present at Citi 2011 Global Health Care Conference Merck,
Published by
Business Wire
28 Feb 11 Fujifilm to Acquire Merck Biomanufacturing Network Merck,
Published by
PharmiWeb.com
28 Feb 11 Fujifilm to Acquire Merck Biomanufacturing Network Merck and FUJIFILM Corporation,
Published by
Business Wire
23 Feb 11 Merck Announces Second Quarter 2011 Dividend Merck,
Published by
Business Wire
14 Feb 11 Merck Wins First FOSAMAX® (alendronate sodium) State Court Trial Merck & Co. Inc.,
Published by
Business Wire
04 Feb 11 Merck Serono Launch Latest in Series of Ongoing Disease Awareness Initiatives Merck Serono,
Published by
PharmiWeb.com
03 Feb 11 Merck Announces Fourth Quarter and Full Year 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
03 Feb 11 New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL® in Males Merck,
Published by
Business Wire
26 Jan 11 John J. Horan, Former Merck Chairman and CEO Dies of Natural Causes at 90 Years of Age Merck,
Published by
Business Wire
20 Jan 11 Merck KGaA and Lead Discovery Center Enter Collaboration for the Discovery of Anti-Cancer Compounds Merck Serono,
Published by
PharmiWeb.com
20 Jan 11 Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar Merck,
Published by
Business Wire
19 Jan 11 Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX Merck Serono,
Published by
PharmiWeb.com
19 Jan 11 Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX Merck Serono,
Published by
Business Wire
13 Jan 11 Merck Statement on Changes to Clinical Studies of Vorapaxar Merck,
Published by
Business Wire
12 Jan 11 Merck and PAREXEL Form Strategic Alliance Focused on Clinical Development of Biosimilar Candidates Merck,
Published by
Business Wire
11 Jan 11 Merck Announces FDA Acceptance of New Drug Application for an Investigational Extended-Release Formulation of JANUMET® (sitagliptin/metformin HCI) for Type 2 Diabetes Merck & Co. Inc.,
Published by
Business Wire
11 Jan 11 Merck to Present at the 29th Annual J.P. Morgan Healthcare Conference Merck,
Published by
Business Wire
06 Jan 11 Boceprevir, Merck’s Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment Merck,
Published by
Business Wire
05 Jan 11 Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3 Merck,
Published by
Business Wire
23 Dec 10 US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL® Merck,
Published by
Business Wire
14 Dec 10 The PATH Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine Merck,
Published by
Business Wire
08 Dec 10 Merck Prices $2.0 Billion Debt Offering Merck & Co. Inc.,
Published by
Business Wire
02 Dec 10 Merck to Acquire SmartCells, Inc. Merck & Co. Inc.,
Published by
Business Wire
30 Nov 10 Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman Merck,
Published by
Business Wire
29 Nov 10 Merck Reports Initial Results of Phase III Study of ISENTRESS® (raltegravir) Investigational Once-Daily Dosing in Treatment-Naïve Adult Patients Infected with HIV-1 Merck & Co. Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.